The Care that you Need...by People that you Trust.
J.Thomas Russell DDS
1030 Xenia Avenue,Yellow Springs, Ohio
Call: (937) 767-7731
http://www.Soundentistry.com
How to Find the Right Dentist for You
About Us
Quality Health Care Information
Friday, May 20, 2011 at 11:34AM Medication Safety Lessons for Patients from Patient Power® on Vimeo.
Dr. Steven Nissen of the Cleveland Clinic, emphasizes the need for patients to be in active dialogue with their physicians and ask the hard questions when they become skeptical about a medication.
Steven E. Nissen (born 1948), is a well-known cardiologist, researcher and patient advocate. He is chairman of cardiovascular medicine at the Cleveland Clinic, in Cleveland, Ohio.[1]
Nissen received his medical degree from the University of Michigan School of Medicine in Ann Arbor. He completed his Internal Medicine internship and residency at the University of California, Davis in Sacramento, thereafter completed his Cardiology Fellowship at the University of Kentucky Medical Center in Lexington.[1]
Joining Cleveland Clinic in 1992, Nissen served as Vice-Chairman of the Department of Cardiology.
While thorough and cautious in evaluation of new drugs, Dr. Nissen also is one of the fields greatest proponents of new treatment investigation. He has explored many experimental drug therapies seeking to halt and even reverse atherosclerosis with promising results.
In 2007, the meta-analysis by Nissen and his co-investigator Kathy Wolksi, published in the Journal of the American Medical Association online on October 20, found that the diabetes drug rosiglitazone (Avandia) produced by GlaxoSmithKline carried high cardiovascular risk